Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cachexia in cancer--zeroing in on myosin

Jeffrey S Chamberlain1

  • 1Department of Neurology, and the Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, University of Washington School of Medicine, Seattle, USA.

The New England Journal of Medicine
|November 13, 2004
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative MRI Assessment of Myotoxin-Induced Skeletal Muscle Damage of mdx Mice.

Muscle & nerve·2026
Same author

Dystrophins DP71 and DP427 determine cell viability during proliferation and myofibre differentiation.

Cell death & disease·2026
Same author

Genetic strategies for therapy of Duchenne muscular dystrophy.

Molecular therapy. Nucleic acids·2025
Same author

Proteomics-based evaluation of AAV dystrophin gene therapy outcomes in mdx skeletal muscle.

JCI insight·2025
Same author

The future of gene therapy: Safer vectors, sharper focus: High-profile failures demand deep root cause analysis - but the transformative potential of AAV remains within reach if the field is willing to learn and evolve.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Bidirectional role of Costameres in the pathophysiology of mdx skeletal muscles.

Human molecular genetics·2025